Market Cap (In CAD)
2.1 Million
Revenue (In CAD)
-
Net Income (In CAD)
-69.44 Million
Avg. Volume
48.35 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.01-0.08
- PE
- -
- EPS
- -
- Beta Value
- 2.038
- ISIN
- CA74449Q1063
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Jody Aufrichtig
- Employee Count
- -
- Website
- https://www.psyence.com
- Ipo Date
- 2021-01-27
- Details
- Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
More Stocks
-
PMMAFPUMA SE
PMMAF
-
002962
-
ORRYYOrora Limited
ORRYY
-
CHI
-
SUNRETAILSun Retail Limited
SUNRETAIL
-
300708
-
CRGP
-
NIRAVCOMNirav Commercials Limited
NIRAVCOM